Home › Funds › Deep Track Capital, LP › CYTK

Deep Track Capital, LP position in CYTK

CYTOKINETICS INC · Health Care

Deep Track Capital, LP reported holding 700,000 shares of CYTK (CYTOKINETICS INC) in its Q2 2026 13F filing — a position valued at US$59.6M, representing 0.89% of its reported portfolio and ranking #36 among its reported holdings. Deep Track Capital, LP has disclosed CYTK holdings in 10 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)700.00K sh
Reported value held$59.63M
Portfolio Weight0.89%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's CYTK position evolved

Deep Track Capital, LP first disclosed a stake in CYTK in Q4 2023 at 288,949 shares (US$24.1M). The position peaked in Q3 2025 at 4,300,000 shares, worth US$236.3M. Across 10 filings, Deep Track Capital, LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 700,000 shares valued at US$59.6M — a reduction of -674,320 shares quarter over quarter.. Notable position changes include a 375% increase in Q3 2024 (shares fell 11% over the following quarter), a 297% increase in Q4 2024 (shares fell 15% over the following quarter), a 59% trim in Q1 2026 (shares rose 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 288.95K $24.12M New
Q2 2024 132.50K $7.18M New
Q3 2024 629.91K $33.26M Add
Q4 2024 2.50M $117.60M Add
Q1 2025 3.07M $123.54M Add
Q2 2025 3.65M $120.60M Add
Q3 2025 4.30M $236.33M Add
Q4 2025 3.34M $212.03M Reduce
Q1 2026 1.37M $90.58M Reduce
Q2 2026 700.00K $59.63M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 51 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has Deep Track Capital, LP held CYTK?

Deep Track Capital, LP has disclosed CYTK holdings in 10 of the last 11 reported quarters, going back to Q4 2023.

What is Deep Track Capital, LP's current position in CYTK?

As of Q2 2026, Deep Track Capital, LP holds 700.00K shares of CYTK (CYTOKINETICS INC), valued at $59.63M, representing 0.89% of its reported portfolio and ranking #36.

Has Deep Track Capital, LP been buying or selling CYTK?

In the latest 13F filing (Q2 2026), Deep Track Capital, LP reduced its position in CYTK. The position peaked in Q3 2025 at 4.30M shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.